Association of Immunity-related Gene SNPs with Alzheimer's Disease

Overview

Journal Exp Biol Med (Maywood)

Specialty Biology

Date 2024 Dec 9

PMID 39651329

Authors

Nisrine Bissar

Rayan Kassir

Ali Salami

Said El Shamieh

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a prevalent neurodegenerative disorder characterized by progressive cognitive decline. Genetic factors have been implicated in disease susceptibility as its etiology remains multifactorial. The and the genes, involved in immune responses, have emerged as potential candidates influencing AD risk. In this study, 644 Lebanese individuals, including 127 AD patients and 250 controls, were genotyped, by KASP assay, for six SNPs selected from the largest GWAS study in 2021. Logistic regression analysis assessed the association between SNP genotypes and AD risk, adjusting for potential confounders. Among the six SNPs analyzed, rs1846190G>A in and rs1354106T>G in showed significant associations with AD risk in the Lebanese population ( < 0.05). Carriers of the AG and AA genotypes of rs1846190 in exhibited a protective effect against AD (AG: OR = 0.042, p = 0.026; AA: OR = 0.052, p = 0.031). The GT genotype of rs1354106T>G in was also associated with reduced risk (OR = 0.173, p = 0.005). Following Bonferroni correction, a significant correlation of rs1354106T > G with AD risk was established. Our results might highlight the complex interplay between genetic and immunological factors contributing to the development of the disease.

References

Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodriguez I, Cadena-Suarez A, Sanchez-Garibay C . Alzheimer's Disease: An Updated Overview of Its Genetics. Int J Mol Sci. 2023; 24(4). PMC: 9966419. DOI: 10.3390/ijms24043754. View

Masri I, Salami A, El Shamieh S, Bissar-Tadmouri N . rs3851179G>A in PICALM is Protective Against Alzheimer's Disease in Five Different Countries Surrounding the Mediterranean. Curr Aging Sci. 2019; 13(2):162-168. DOI: 10.2174/1874609812666191019143237. View

Apostolova L, Green A, Babakchanian S, Hwang K, Chou Y, Toga A . Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease. Alzheimer Dis Assoc Disord. 2012; 26(1):17-27. PMC: 3286134. DOI: 10.1097/WAD.0b013e3182163b62. View

Knopman D, Amieva H, Petersen R, Chetelat G, Holtzman D, Hyman B . Alzheimer disease. Nat Rev Dis Primers. 2021; 7(1):33. PMC: 8574196. DOI: 10.1038/s41572-021-00269-y. View

Wang Z, Wan Q, Xing A . HLA in Alzheimer's Disease: Genetic Association and Possible Pathogenic Roles. Neuromolecular Med. 2020; 22(4):464-473. DOI: 10.1007/s12017-020-08612-4. View

Villemagne V, Pike K, Chetelat G, Ellis K, Mulligan R, Bourgeat P . Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol. 2011; 69(1):181-92. PMC: 3045039. DOI: 10.1002/ana.22248. View

Silva M, Mello Gomide Loures C, Alves L, de Souza L, Borges K, Carvalho M . Alzheimer's disease: risk factors and potentially protective measures. J Biomed Sci. 2019; 26(1):33. PMC: 6507104. DOI: 10.1186/s12929-019-0524-y. View

Jiao B, Liu X, Zhou L, Wang M, Zhou Y, Xiao T . Polygenic Analysis of Late-Onset Alzheimer's Disease from Mainland China. PLoS One. 2015; 10(12):e0144898. PMC: 4683047. DOI: 10.1371/journal.pone.0144898. View

Aliseychik M, Andreeva T, Rogaev E . Immunogenetic Factors of Neurodegenerative Diseases: The Role of HLA Class II. Biochemistry (Mosc). 2018; 83(9):1104-1116. DOI: 10.1134/S0006297918090122. View

10.

Tortora F, Rendina A, Angiolillo A, di Costanzo A, Aniello F, Donizetti A . CD33 rs2455069 SNP: Correlation with Alzheimer's Disease and Hypothesis of Functional Role. Int J Mol Sci. 2022; 23(7). PMC: 8998932. DOI: 10.3390/ijms23073629. View

11.

DeTure M, Dickson D . The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener. 2019; 14(1):32. PMC: 6679484. DOI: 10.1186/s13024-019-0333-5. View

12.

Bellenguez C, Kucukali F, Jansen I, Kleineidam L, Moreno-Grau S, Amin N . New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022; 54(4):412-436. PMC: 9005347. DOI: 10.1038/s41588-022-01024-z. View

13.

Griciuc A, Serrano-Pozo A, Parrado A, Lesinski A, Asselin C, Mullin K . Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013; 78(4):631-43. PMC: 3706457. DOI: 10.1016/j.neuron.2013.04.014. View

14.

Wang W, Liu Y, Wang H, Tan L, Sun F, Tan M . Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment. Mol Neurobiol. 2016; 54(2):1111-1118. DOI: 10.1007/s12035-016-9718-4. View

15.

Lambert J, Ibrahim-Verbaas C, Harold D, Naj A, Sims R, Bellenguez C . Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013; 45(12):1452-8. PMC: 3896259. DOI: 10.1038/ng.2802. View

16.

de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen I . Common variants in Alzheimer's disease and risk stratification by polygenic risk scores. Nat Commun. 2021; 12(1):3417. PMC: 8184987. DOI: 10.1038/s41467-021-22491-8. View

17.

Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J, Carrasquillo M . Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011; 43(5):429-35. PMC: 3084173. DOI: 10.1038/ng.803. View

18.

Ramanan V, Heckman M, Przybelski S, Lesnick T, Lowe V, Graff-Radford J . Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden. J Alzheimers Dis. 2022; 88(4):1615-1625. PMC: 9534315. DOI: 10.3233/JAD-220164. View

19.

Wes P, Sayed F, Bard F, Gan L . Targeting microglia for the treatment of Alzheimer's Disease. Glia. 2016; 64(10):1710-32. DOI: 10.1002/glia.22988. View

20.

Streit W, Mrak R, Griffin W . Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation. 2004; 1(1):14. PMC: 509427. DOI: 10.1186/1742-2094-1-14. View